EXC · 10-Q · 2026Q3 · Full report

Net Income Performance

EXELON CORP · 2026-10-30 · Importance 29 · Surprise 40

Exelon’s third-quarter 2026 net income attributable to common shareholders decreased $146 million year over year, and diluted EPS fell 18.6%, from $0.86 to $0.70. For the first nine months of 2026, net income declined $130 million and diluted EPS decreased from $2.15 to $1.98. The company attributed the quarterly decline principally to Pepco Maryland rate-case write-offs, PECO and PHI storm costs, higher interest expense, BGE project impairments, and higher depreciation at PECO and PHI.

Key facts

• Exelon’s net income attributable to common shareholders decreased by $146 million for the three months ended September 30, 2026, and diluted earnings per average common share fell to $0.70 from $0.86 in 2025.
• Exelon recognized $0.13 per diluted share of regulatory-matters adjustments for the three months ended September 30, 2026, net of $50 million in taxes.
• Exelon recognized $0.14 per diluted share of regulatory-matters adjustments for the nine months ended September 30, 2026, net of $54 million in taxes.
• Exelon’s net income attributable to common shareholders decreased by $130 million for the nine months ended September 30, 2026, and diluted earnings per average common share fell to $1.98 from $2.15 in 2025.
• Exelon’s adjusted operating earnings were $2,265 million, or $2.20 per diluted share, for the nine months ended September 30, 2026, compared with $2,198 million, or $2.17 per diluted share, in 2025.
• Exelon’s adjusted operating earnings were $0.87 per diluted share for the three months ended September 30, 2026, compared with $0.86 in 2025.